Answers are grounded in this paper and cite their sources.
PURPOSE Application of technology has revolutionized strategy for screening for pre-invasive lesions of the cervix. Self-testing for HPV has been shown to be an effective screening strategy for pre-invasive lesions of the cervix and it is currently being advocated as the method of choice because of inherent convenience to the woman in comparison to clinician collected sampling for HPV. We hereby report on feasibility of self-administered treatment of pre-invasive lesions of the cervix. METHODS A desk review of historical treatment and current advances in the treatment for pre-invasive lesions of the cervix was conducted with the view of identifying treatment options that can be explored for self-treatment. RESULTS Historically the treatment of pre-invasive invasive lesions of the cervix has been grouped into excision and ablative methods. Following the identification of HPV as a causative agent for cervical cancer and successful development of a prophylactic vaccine against the virus, efforts are now being directed at developing a therapeutic vaccine against the virus that can reverse the cytopathologic changes induced by the virus. Similarly, a number of active pharmaceutical ingredients (API) such as lactobacillus crisaptous, a vaginal probiotic, EGCG, an oxidant agent found in green tea which have been shown to accelerate HPV clearance with potential to reverse cytological changes are novel agents that can be explored for self-treatment. CONCLUSION Self-treatment of pre-invasive lesions of the cervix is a clinically feasible option that should be further explored for its potentials of convenience to the women and ability to bridge the current treatment gaps in low resource settings.
No takes yet. Share an insight, caveat, or question.
Lawal et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: